Channels - To screen or not to screen: complexity of SDHA mutation management :: FRELIP Discovery

Similar Items: To screen or not to screen: complexity of SDHA mutation management

Quick Look
Cancer Prevalence Among Large Cohort of Individuals With Down Syndrome: Implications for Screening Guidelines
Quick Look
Awareness of Lung Cancer Signs and Symptoms, Risk Factors, and Screening in Jordan: Cross-Sectional Study
Quick Look
Online Intervention on Lung Cancer Screening Among High-Risk Individuals: Pilot Intervention Study
Quick Look
A Personalised and Gamified Digital Decision Aid for Colorectal Cancer Screening: A Randomised Controlled Pilot Study
Quick Look
Correction to ‘A Personalised and Gamified Digital Decision Aid for Colorectal Cancer Screening: A Randomised Controlled Pilot Study’
Quick Look
Changes in Distress Screening and Information Reception Among Cancer Patients Following a Training for Oncology Nursing Staff: A Pilot Study
Quick Look
Colorectal Cancer Screening Beyond Primary Care: A Community‐Based FIT Distribution Model Serving a Safety‐Net Hospital Population
Quick Look
Analysis of Age, Period and Cohort Trends in Cervical In Situ and Invasive Carcinomas for Assessing the Utility of Screening Approaches—Results From the Saarland Cancer Registry
Quick Look
Association Between Osimertinib Dose Reduction and Treatment Outcomes in First‐Line EGFR‐Mutated Advanced NSCLC: The Impact of Post‐Progression Management
Quick Look
Interrogating the immune landscape of microsatellite stable RAS‐mutated colon cancer
Quick Look
Gain and Loss of Mutations in Patients with Acute Myeloid Leukemia: A Noninterventional Cohort Study (CLEVO)
Quick Look
Pre‐analytical optimization of cell‐free DNA and extracellular vesicle‐derived DNA for mutation detection in liquid biopsies
Quick Look
Pharmacoeconomic Analysis of Osimertinib Compared to Earlier‐Generation EGFR Inhibitors in EGFR‐Mutated NSCLC: A Systematic Review
Quick Look
EGFR Mutations and Recurrence Outcomes in Resected Non‐Small Cell Lung Cancer: An Updated 2015–2025 Systematic Review and Meta‐Analysis
Quick Look
Retrospective Analysis of HER2 Testing, Treatment Patterns, and Clinical Outcomes in Patients With Locally Advanced or Metastatic NSCLC With HER2 Mutations in France
Quick Look
An Observational Study of Afatinib 30 mg Daily in Patients With Advanced Non‐Small‐Cell Lung Cancer Harboring Common EGFR Mutations Treated With Afatinib
Quick Look
MET Dependence Oversteps EGFR Dependence via Balancing Dimerization of the Receptor Tyrosine Kinases in Osimertinib‐Resistant MET‐Amplified, EGFR‐Mutated Non‐Small Cell Lung Cancer
Quick Look
Acquired BRAF-AGK Fusion Following Osimertinib Plus Savolitinib in EGFR-Mutated MET-Amplified Non-Small-Cell Lung Cancer: Durable Response to Gefitinib and Trametinib in a Case Report
Quick Look
Enhancing Oncological Care for India's Aging Population: Addressing the Complex Needs of Older Adults With Cancer
Quick Look
Single‐nucleotide polymorphisms in coronary artery disease: Biological complexity, risk architecture, and implications for precision prevention
Quick Look
Expression Profiling of SWI/SNF Complex Subunits in Triple-Negative Breast Cancer Using Tissue Microarray and Immunohistochemistry
Quick Look
ZW4864‐mediated inhibition of the β‐catenin/BCL9/BCL9L complex reveals therapeutic potential in bladder cancer
Quick Look
Management of malignant bowel obstruction in patients with advanced cancer at the end of life
Quick Look
Optimal management of venous thromboembolism in adolescent and young adult oncology patients